Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia

Dylan A. Mordaunt, Kim Dalziel, Ilias Goranitis, Zornitza Stark

Research output: Contribution to journalComment/debate

7 Citations (Scopus)
39 Downloads (Pure)

Abstract


Lack of reimbursement for genomic testing in rare diseases is recognized as one of the principal barriers to wider implementation within healthcare systems [1]. Multiple studies have provided evidence for diagnostic and clinical utility and for the cost-effectiveness of genomic testing in rare diseases, leading to testing being funded across a range of public and private healthcare systems worldwide [2].
Original languageEnglish
Pages (from-to)977-979
Number of pages3
JournalEuropean Journal of Human Genetics
Volume31
Issue number9
Early online date3 Jul 2023
DOIs
Publication statusPublished - Sept 2023
Externally publishedYes

Keywords

  • economics
  • health care
  • health care economics
  • health policy

Fingerprint

Dive into the research topics of 'Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia'. Together they form a unique fingerprint.

Cite this